Intended for erectile dysfunction to manage blood flow and support sustained physiological response during stimulation.
Mechanism of Action
This medication combines two PDE5 inhibitors to provide both immediate and sustained effects. By increasing cGMP levels, it promotes prolonged smooth muscle relaxation and enhanced blood flow in penile tissues during arousal.
Route of Administration
Oral
Onset Time
30–60 minutes
Duration
24–36 hours
Contraindications
Concurrent use of nitrates, Hypersensitivity to any component, Severe heart disease
Information related to Tadasiva is compiled and periodically reviewed with reference to established medical sources and prescribing guidance. Content is provided for general reference and should be confirmed with a registered healthcare professional before use.
